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ChromatinFive members of the KMT2 family of lysine methyltransferases, originally named the mixed lineage leukemia
(MLL1-5) proteins, regulate gene expression during embryogenesis and development. Each KMT2A-E contains
a catalytic SET domain that methylates lysine 4 of histone H3, and one or several PHD ﬁngers. Over the past
few years a growing number of studies have uncovered diverse biological roles of the KMT2A-E PHD ﬁngers, im-
plicating them in binding to methylated histones and other nuclear proteins, and in mediating the E3 ligase ac-
tivity and dimerization. Mutations in the PHD ﬁngers or deletion of these modules are linked to human diseases
including cancer andKabuki syndrome. In thiswork, we summarize recently identiﬁed biological functions of the
KMT2A-E PHD ﬁngers, discuss mechanisms of their action, and examine preference of these domains for histone
and non-histone ligands.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The lysinemethyltransferases KMT2A-E are evolutionarily conserved
transcriptional regulators. They play a key role in embryogenesis and
maintenance of the expression levels of HOX and other developmental
genes and are essential in the cell cycle control, hormone signaling and
reproduction [1–5]. Chromosomal translocations, tandem duplications,
deletions andmutations in the KMT2A-E genes have been directly linked
to leukemogenesis and other humandiseases [2,6–8]. The KMT2A-E sub-
family consists of ﬁve members, including KMT2A (or MLL1), KMT2B
(MLL2), KMT2C (MLL3), KMT2D (MLL4) and KMT2E (MLL5), which
together with KMT2F (SET1A) and KMT2G (SET1B) constitute a larger
family of KMT2 methyltransferases. The KMT2 enzymes are highly
speciﬁc and catalyze the transfer of methyl groups from S-adenosyl-L-
methionine (SAM) to the ε-amino group of lysine 4 of histone H3, gener-
ating mono-, di- or tri-methylated H3K4me1/2/3 marks.
To say that KMT2A-E are complex macromolecules is understate-
ment. These very large, ~300–600 kDa multimodular proteins interact
with numerous ligands, at times recruiting co-factors with apparently
opposing functions. KMT2A alone has over a dozen of binding partners
and is cleaved into two pieces, a larger N-terminal fragment, involved in
gene repression, and a smaller C-terminal fragment, which is a tran-
scriptional activator [9,10]. The cleavage, followed by the association
of the two fragments, is necessary for KMT2A to be fully active. Like
many other methyltransferases, the KMT2 family members exist in
multisubunit nuclear complexes (human COMPASS), where other sub-
units also mediate the enzymatic activity [11,12]. Furthermore, the.G. Kutateladze).
ights reserved.KMT2 function can be ﬁne-tuned by posttranslational modiﬁcations
(PTMs). For example, KMT2E has no intrinsic histone lysine methyl-
transferase activity [13], however, once the SET (Su(var)3–9, Enhancer
of Zeste, Trithorax) domain is glycosylated, it is capable of generating
mono- and dimethylated H3K4 marks [14].
KMT2A-E can be distinguished through the catalytic SET domain,
however the number of PHD ﬁngers found in these proteins differs con-
siderably. Four PHD ﬁngers are present in KMT2A and KMT2B, whereas
KMT2C, KMT2D and KMT2E have eight, seven, and one, respectively
(Fig. 1a). Overall, the KMT2A-E subfamily contains 24 PHD ﬁngers,
each of which is characterized by the canonical C4HC2C/H sequence
that coordinates two zinc ions (Fig. 1b). A number of studies in the
last few years revealed diverse roles of the KMT2A-E PHD ﬁngers.
Here, we compare known biological activities of the PHD ﬁngers and
discuss the molecular mechanisms underlying these functions. We
also explore the conservation of the PHD-ligand interactions within
the KMT2A-E subfamily.2. PHD ﬁngers of KMT2A and KMT2B
KMT2A and KMT2B have similar domain architecture and both
contain three consecutive PHD ﬁngers (PHD1–PHD3), followed by a
bromodomain (BD) and the fourth PHD4 ﬁnger. The ﬁrst and second
modules in the triple PHD1–3 ﬁnger cassette are closely linked, whereas
the third module is separated from PHD1–PHD2 by an additional single
C4-type zinc ﬁnger. The PHD ﬁnger region plays a regulatory role in
KMT2A function and suppresses KMT2A-mediated leukaemogenesis.
Inclusion of the PHD2–PHD3 ﬁngers in the chimeric KMT2A-AF9 in-
hibits transformation ofmouse bonemarrow and leads to hematopoiet-
ic cell differentiation and downregulation of Hoxa9 [15]. Incorporation
Fig. 1. The KMT2A-E subfamily of lysine methyltransferases. (a) Schematic representation of the KMT2A-E subfamily. The 24 PHD ﬁngers and single zinc-ﬁngers are depicted as orange
ovals and small brown circles, respectively. (b) Alignment of the KMT2A-E PHD ﬁnger sequences: absolutely, moderately and weakly conserved residues are colored orange, yellow
and blue, respectively. Zinc-coordinating cysteine/histidine residues are labeled.
Fig. 2. The structural basis of the interactions of KMT2A PHD3 with H3K4me3 and Cyp33. (a) The 1.9 Å-resolution crystal structure of the PHD3-BD region of KMT2A in complex with
histone H3K4me3 peptide (PDB: 3LQJ). (b) The H3K4me3-binding site of the KMT2A PHD3 ﬁnger. (c) The solution structure of the Cyp33 RRM domain fused with the α1-helix of the
KMT2A PHD3 ﬁnger (PDB: 2KU7).
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Fig. 3. Solution structure of the tandem PHD2–PHD3 ﬁngers of KMT2C. (a) A ribbon dia-
gram of the structure (PDB: 2YSM, unpublished, RIKEN). (b) Electrostatic potential map
of PHD2–PHD3. Red and blue color represents negative charge and positive charge,
respectively.
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immortalization of murine bone marrow progenitor cells [16].
Although the precise function of the PHD1 ﬁnger remains poorly
understood, it cooperates with PHD4 in mediating intramolecular inter-
actions between the N-terminal and C-terminal fragments of KMT2A
[17]. The PHD2 ﬁnger of KMT2A and KMT2B shows the E3 ubiquitin li-
gase activity in the presence of the E2-conjugating enzyme CDC34 [18].
It ubiquitinates histones H3 and H4 in vitro and plays a role in the
ubiquitination of KMT2A itself, which may provide a mechanism for
the regulation of KMT2Adegradation during cell cycle [18]. In agreement,
disruption of the PHD2 ﬁnger fold or deletion of this domain enhances
recruitment of KMT2A to target genes and augments its transactivation
ability, most likely due to the increased protein stability. Additionally,
the PHD2 ﬁnger of KMT2A is involved in homo-dimerization [19].
The third PHD3ﬁnger of KMT2A ismost structurally and functionally
characterized. This unique zinc ﬁnger has two binding partners: it
recognizes histone H3K4me3, the product of the KMT2A enzymatic ac-
tivity, and interacts with the RNA recognitionmotif (RRM) of the nucle-
ar cyclophilin Cyp33, an KMT2A-associated co-repressor [16,19–24].
Several recent studies shed light on themolecular basis of these interac-
tions [20–22,24] andWang et. al. have uncovered a remarkably complex
mechanism for the association of PHD3 with H3K4me3 and Cyp33 [20].
The crystal structure of the PHD3-BD region of KMT2A reveals that
in the apo-state the two domains are in close contact, mediated by
the bended α1-helix of PHD3 and the extended αZ helix and the C-
terminal loop of BD [20]. A proline residue in the short linker connecting
PHD3 and BD adopts a cis conformation, thus allowing for the formation
of a pair of inter-domain salt bridges and leading to the overall compact
PHD3-BD assembly. Unlike other acetyllysine-recognizing BDs, the
bromodomain of KMT2A does not bind acetylated lysine residues, how-
ever it plays an essential role in modulating functions of the PHD3 ﬁn-
ger, inﬂuencing its interaction with both H3K4me3 and Cyp33. In the
presence of BD, binding afﬁnity of the PHD3 ﬁnger for H3K4me3 is en-
hanced ~20 fold, whereas association with an isolated Cyp33 RRM do-
main is abolished because BD blocks the RRM-binding site. The latter
interaction can be restored if full-length Cyp33 is used. Cyp33 is a
peptidyl-prolyl isomerase (PPIase) that catalyzes cis–trans isomeriza-
tion of proline residues. Here, it converts a Pro–His peptide bond in
the PHD-BD linker from the cis to trans conformation, consequently
disrupting the PHD3-BD contacts and releasing the previously occluded
RRM-binding site of PHD3 [20].
As many other epigenetic readers [25], the KMT2A PHD3 ﬁnger ex-
hibits a low μM binding afﬁnity for H3K4me3 (Kd = 4 μM, 19 μM and
30 μM, as measured by ITC and tryptophan ﬂuorescence [20–22]) and
binds weaker to di- or mono-methylated H3K4. The 1.9 Å-resolution
crystal structure of PHD3-BD in complex with histone H3K4me3 pep-
tide demonstrates that the KMT2A PHD3 ﬁnger recognizes this PTM
through a conserved mechanism [20] (Fig. 2a, b). H3K4me3 adopts an
extended conformation and pairs with the β-sheet of PHD3, forming
characteristic backbone–backbone intermolecular hydrogen bonds. The
fully extended side chain of trimethylated K4 occupies an aromatic/
hydrophobic cage, consisting of two tyrosine residues (Y1576 and
Y1581), a methionine (M1585), and a tryptophan (W1594) that make
cation-π, hydrophobic and van der Waals contacts with the
trimethylammonium group of K4. The bulky side chain of W1594 sepa-
rates the K4me3-binding cage from the adjacent R2-binding groove,
where N1587 of the protein is hydrogen bonded to the ε guanidinium
proton of R2. Yet, the H3K4me3-binding mechanism of KMT2A PHD3
has several unique features: the bound peptide makes a β turn at the
K4me3-Q5 step, and this interaction induces a conformational change
in the Y1576–M1585 loop whereby Y1581 ﬂips toward the aromatic
cage, almost fully enclosing bound K4me3. Substitution of the aromatic
cage residues disrupts the interaction with H3K4me3.
Binding of KMT2A PHD3 to RRM involves α1-helix of the PHD3 ﬁn-
ger, the same helix that associates with BD. This helix lays across the
central β-sheet of RRM, as seen in the solution structure of the Cyp33RRM domain fused with the α1-helix of the PHD3 ﬁnger [20] and
fromchemical shift perturbation analyses [20,22,24] (Fig. 2c). This inter-
action is mediated primarily through hydrophobic contacts involving the
side chains of M1606, I1609 and L1610 of PHD3. The RRM-binding site
is adjacent to and does not visibly overlap with the H3K4me3-binding
site, however the PHD-BD region binds to H3K4me3 ~3-fold weaker
when full-length Cyp33 is present [20]. Likewise binding of an isolated
PHD3 ﬁnger is reduced ~6-fold in the presence of RRM, and the interac-
tion of PHD3with Cyp33 is ~4-foldweaker in the presence of H3K4me3
[22]. Itwill be interesting to explore the interplay between these two in-
teractions in detail and establishwhether the PHD3ﬁnger is able to con-
comitantly associate with both binding partners in vivo.
The KMT2APHD3 ﬁnger is a striking example of a PTM readerwhose
function depends on the epigenetic environment and can be switch-
ed from transcriptional activation to repression through binding to
H3K4me3 or Cyp33. Surprisingly, the Cyp33 binding activity is not con-
served in the PHD3 ﬁnger of KMT2B, despite high sequence similarity of
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ed to the replacement of a single residue M1606 in the α1-helix of
KMT2A PHD3 by an aspartate in KMT2B PHD3. Swapping mutations
(M1606D in KMT2A and D1375M in KMT2B, respectively) conﬁrmed
that the methionine is required for the interaction with Cyp33 [20].
3. PHD ﬁngers of KMT2C and KMT2D
KMT2C and KMT2D contain eight and seven PHD ﬁngers, respectively
(Fig. 1a). Although the biological role of the KMT2C PHD ﬁngers is un-
known, the atomic-resolution NMR structure of the tandem PHD2-PHD3
ﬁngers of KMT2C (PDB: 2YSM, unpublished, RIKEN) implies that these do-
mainsmay function in concert. In the structure, bothdomains adopt a typ-
ical zinc-ﬁnger fold [26] but have a large interface that holds the PHD
ﬁngers together in a bean-shaped scaffold (Fig. 3). Notably, PHD2, and
the concave surface of the tandemdomains in general, is highly negatively
charged, whereas the opposite side (PHD3 particularly) is highly positive-
ly charged (Fig. 3b). Such charge distribution may indicate a role of elec-
trostatic contacts in functioning of the KMT2C PHD2–PHD3 ﬁngers.
A triple PHD ﬁnger cassette (PHD4–6) of KMT2D associates with
histone H4 either unmodiﬁed or asymmetrically dimethylated at R3
(H4R3me2a) [27]. This interaction is required for methyltransferase
activity of KMT2D and for KMT2D-mediated differentiation, and is
inhibited by symmetric dimethylation of R3. Kabuki syndrome muta-
tions C1430R and C1471Y [8], whichmost likely disrupt the PHD5ﬁnger
fold, reduce histone binding and catalytic activity of KMT2D [27].
4. PHD ﬁnger of KMT2E
A single PHD ﬁnger of KMT2E recognizes histone H3K4me3 with
high speciﬁcity and afﬁnity [28,29]. The 1.48 Å resolution crystal struc-
ture of the PHD-H3K4me3 complex shows that the histone peptide lays
antiparallel to and pairs with the double-stranded β sheet of the protein
[28]. The side chain of trimethylated K4 is bound in an elongated groove
formed by the D128, M132 and W141 residues of the PHD ﬁnger
(Fig. 4a). The N-terminal amino group of A1 is hydrogen bonded to
two backbone carbonyl groups of the protein, whereas the methyl
group of A1 is buried in a small hydrophobic cavity. Additional intermo-
lecular hydrogen bonds restrain Q5 and T6 of the peptide.Fig. 4. Themolecular mechanism of H3K4me3 recognition by the KMT2E PHD ﬁnger. (a) The 1.
tide (PDB: 4L58). The K4me3-binding groove residues are colored yellow and labeled. (b) An o
structure of KMT2E PHD in the apo-state (gray) (PDB: 2LV9). TheH3K4me3 peptide is omitted f
the N-terminal loop and the C-terminalα1-helix. Dashed lines represent hydrogen bonds. (d) A
residues are indicated by red circles and labeled. Secondary structure elements of KMT2E PHDThe three unique aspects of the H3K4me3-binding mode of the
KMT2E PHD ﬁnger are evident [28] (Fig. 4). In contrast to other PHD
ﬁngers, the K4me3-binding groove of KMT2E PHD contains only one ar-
omatic residue,W141,with the acidic residueD128 forming anopposite
(toW141)wall of the groove (Fig. 4d). The presence of an acidic residue
in the aromatic cage of epigenetic readers is known to drive their pref-
erence for di- or monomethylated over trimethylated lysine substrates
(reviewed in [25]). The carboxyl group of an aspartate can form addi-
tional favorable hydrogen bonding contacts with di- or mono- but not
with tri-methylammonium group of K4. In spite of this, the KMT2E
PHD ﬁnger selects for H3K4me3.
An overlay of the crystal structure of the KMT2E PHD ﬁnger in com-
plex with H3K4me3 peptide and the solution structure of the apo-state
reveals that binding is accompanied by large conformational changes in
the protein N-terminal loop [28,29] (Fig. 4b). In the ligand-free state,
D128 points toward the C-terminalα1-helix, whereas the preceding res-
idue H127 points toward the K4me3-binding groove. Upon binding to
H3K4me3, H127 and D128 swap their positions. The side chains of
H127 and D128 swing in opposite directions, each by almost 180°. H127
moves away from the groove and interacts with the α1-helix. Concomi-
tantly, D128 dissociates from the α1-helix and ﬂips inward to complete
the K4me3-binding pocket. The H127–D128 swapping rearrangement
causes conformational changes in other residues of the G124–Y131 loop.
The involvement of the α1-helix of KMT2E PHD underlines another
distinctive feature of this binding mechanism. The unusually long C-
terminalα1-helix of KMT2E PHD is in direct contact with and stabilizes
the core of the domain. It packs against the N-terminal loop and the 310
helix, creating an intricate set of hydrogen bonding, electrostatic and
hydrophobic interactions at the interface (Fig. 4c). This helix is located
further downstream in sequence as compared to a typical α1-helix of
KMT2A PHD3, which is involved in the interaction with Cyp33 and BD
(Fig. 4d).
5. Conservation of histone and RRM binding activities within the
KMT2A-E subfamily
Analysis of amino acid sequences of the H3K4me3-speciﬁc PHD ﬁn-
gers indicates a critical role of a tryptophan residue at position -2 with
respect to zinc-coordinating histidine [26,30]. Because six of the 2448 Å resolution crystal structure of the KMT2E PHD ﬁnger in complex with H3K4me3 pep-
verlay of the structure of the H3K4me3-bound KMT2E PHD ﬁnger (dark yellow) with the
or clarity. (c) A zoom-in viewof the KMT2E PHD structure showing close contacts between
lignment of sequences of the KMT2E and KMT2A PHD ﬁngers. The K4me3-binding groove
and KMT2A PHD3 are shown.
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(Fig. 5a), we sought to examine whether they are capable of histone
binding. We expressed and puriﬁed KMT2A PHD3, KMT2B PHD3,
KMT2C PHD7, KMT2D PHD6 and KMT2E PHD ﬁngers as 15N-labeled
proteins and tested their interactions with H3K4me3 peptide using
1H,15N HSQC experiments (we were unable to obtain cDNA of KMT2C
PHD4) (Fig. 5). As expected, H3K4me3 induced chemical shift changesFig. 5. Conservation of histone and RRM binding activities within the KMT2A–E subfamily. (a
residues are colored orange, yellow and blue, respectively. The K4me3-binding site residues ar
with Cyp33 is marked with a purple square. (b, c) Superimposed 1H,15N HSQC spectra of the
RRM domain (c). Spectra are color coded according to the protein:ligand molar ratio. The follo
(1334–1397), KMT2C PHD7 (1083–1143), KMT2D PHD6 (1486–1572), KMT2E PHD (117–181)
tration experiments were performed at 298 K on Varian INOVA 500 MHz and 600 MHz spect
HSQC spectra of 0.1–0.2 mM uniformly 15N-labeled PHD ﬁngers of KTM2A-E as the unlabeled
of binding activities of the tested KMT2A-E PHD ﬁngers. (e) Control: the KMT2A PHD1 ﬁnger
HSQC spectra of the KMT2A PHD1 ﬁnger recorded upon titration of H3K9me2 peptide. No binin the KMT2A PHD3 and KMT2E PHD ﬁngers, corroborating previous
ﬁndings that the two PHD ﬁngers recognize H3K4me3 [20–22,28,29]
(Fig. 5b, ﬁrst row, ﬁrst panel, and second row, second panel). Likewise,
KMT2B PHD3 exhibited substantial resonance perturbations and thus
associatedwith H3K4me3 (Fig. 5b,ﬁrst row, second panel). Surprisingly
we found that the KMT2C PHD7 and KMT2D PHD6 ﬁngers do not bind
H3K4me3 as their 1H,15N HSQC spectra remain unperturbed upon) Alignment of the PHD ﬁnger sequences: absolutely, moderately and weakly conserved
e indicated by red circles. The M1606 residue of KMT2A PHD3, critical for the interaction
indicated PHD ﬁngers collected upon titration with H3K4me3 peptide (b) or the Cyp33
wing constructs: KMT2A PHD1 (1431–1481), KMT2A PHD3 (1565–1627), KMT2B PHD3
and Cyp33 RRM (1–83) were expressed and puriﬁed as described in [21,24]. The NMR ti-
rometers. The binding was characterized by monitoring chemical shift changes in 1H,15N
histone H3K4me3 peptide or the Cyp33 RRM domain was gradually added. (d) Summary
is folded and stable but has no detectable histone binding activity. Superimposed 1H,15N
ding was observed to unmodiﬁed H3 as well (data not shown).
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ﬁrst panel). These results suggest that not only the signature tryptophan
but also other residues are necessary for this interaction. The obvious
candidates for further studies are the isoleucine and leucine residues,
present in the KMT2C PHD7 and KMT2D PHD6 sequences instead of a
methionine in the KMT2A PHD3 and KMT2E PHD sequences. We note
however, that this methionine is not strictly conserved and is replaced
by a tyrosine in BPTF PHD or by a tryptophan in KDM5A PHD3, and
both these domains are well known to bind H3K4me3 [31–33] (Fig. 5a).
On the other hand and also unexpectedly, KMT2C PHD7 was able to
associate with the RRM domain of Cyp33, despite it lacks the methio-
nine residue in a putative α1-helix, which is required for binding of
KMT2A PHD3 to Cyp33 (Fig. 5c). Indeed, substitution of this methionine
with an aspartic acid in KMT2B PHD3 ﬁnger completely disrupted the
interaction with Cyp33 (Fig. 5c, second panel).
The binding properties of the ﬁve tested PHD ﬁngers are summa-
rized in the table (Fig. 5d). However to fully understand the biological
activities of KMT2A-E and the various cellular processes they facilitate,
it is imperative to identify and characterize functions of all 24 PHD ﬁn-
gers present in this subfamily. As binding partners for the majority of
these domains are challenging to predict, high-throughput assays and
combinatorial approaches can be of substantial help in the identiﬁcation
of both physiological ligands and synthetic drugs for the PHD ﬁngers.
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